CDC-Authored Genomics and Precision Health Publications Database
Last data update: Sep 30, 2024. (Total: 6327 publications)
| Query Trace: Pharmacogenomics[original query] |
|---|
| DPYD genotyping recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, American College of Medical Genetics and Genomics, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, Pharmacogenomics Knowledgebase, and Pharmacogene Variation Consortium
Pratt VM , Cavallari LH , Fulmer ML , Gaedigk A , Hachad H , Ji Y , Kalman LV , Ly RC , Moyer AM , Scott SA , Turner AJ , van Schaik RHN , Whirl-Carrillo M , Weck KE . J Mol Diagn 2024 |
| CYP3A4 and CYP3A5 genotyping recommendations: A joint consensus recommendation of the Association for Molecular Pathology, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, and Pharmacogenomics Knowledgebase
Pratt VM , Cavallari LH , Fulmer ML , Gaedigk A , Hachad H , Ji Y , Kalman LV , Ly RC , Moyer AM , Scott SA , van Schaik RHN , Whirl-Carrillo M , Weck KE . J Mol Diagn 2023 25 (9) 619-629 |
| TPMT and NUDT15 Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, and Pharmacogenomics Knowledgebase.
Pratt VM , Cavallari LH , Fulmer ML , Gaedigk A , Hachad H , Ji Y , Kalman LV , Ly RC , Moyer AM , Scott SA , van Schaik RHN , Whirl-Carrillo M , Weck KE . J Mol Diagn 2022 24 (10) 1051-1063 |
| Emerging Concepts in Precision Medicine and Cardiovascular Diseases in Racial and Ethnic Minority Populations.
Mensah GA , Jaquish C , Srinivas P , Papanicolaou GJ , Wei GS , Redmond N , Roberts MC , Nelson C , Aviles-Santa L , Puggal M , Green Parker MC , Minear MA , Barfield W , Fenton KN , Boyce CA , Engelgau MM , Khoury MJ . Circ Res 2019 125 (1) 7-13 
|
| HLBS-PopOmics: an online knowledge base to accelerate dissemination and implementation of research advances in population genomics to reduce the burden of heart, lung, blood, and sleep disorders.
Mensah GA , Yu W , Barfield WL , Clyne M , Engelgau MM , Khoury MJ . Genet Med 2018 21 (3) 519-524
|
| Attitudes of clinicians following large-scale pharmacogenomics implementation.
Peterson JF , Field JR , Shi Y , Schildcrout JS , Denny JC , McGregor TL , Van Driest SL , Pulley JM , Lubin IM , Laposata M , Roden DM , Clayton EW . Pharmacogenomics J 2015 16 (4) 393-8 |
| Prioritizing genomic applications for action by level of evidence: a horizon-scanning method.
Dotson WD , Douglas MP , Kolor K , Stewart AC , Bowen MS , Gwinn M , Wulf A , Anders HM , Chang CQ , Clyne M , Lam TK , Schully SD , Marrone M , Feero WG , Khoury MJ . Clin Pharmacol Ther 2013 95 (4) 394-402
|
| 2012 highlights in translational 'omics.
Auffray C , Caulfield T , Khoury MJ , Lupski JR , Schwab M , Veenstra T . Genome Med 2013 5 (1) 10
|
| The arrival of genomic medicine to the clinic is only the beginning of the journey.
Evans JP , Khoury MJ . Genet Med 2013 15 (4) 268-9
|
| Varenicline for smoking cessation: nausea severity and variation in nicotinic receptor genes.
Swan GE , Javitz HS , Jack LM , Wessel J , Michel M , Hinds DA , Stokowksi RP , McClure JB , Catz SL , Richards J , Zbikowski SM , Deprey M , McAfee T , Conti DV , Bergen AW . Pharmacogenomics J 2012 12 (4) 349-58 |
| Is there a need for PGxceptionalism?
Khoury MJ , Gwinn M , Dotson WD , Bowen MS . Genet Med 2011 13 (10) 866-7
|
| Pharmacogenetics, pharmacogenomics, and individualized medicine
Ma Q , Lu AY . Pharmacol Rev 2011 63 (2) 437-59 |
| Cancer pharmacogenomics and pharmacoepidemiology: setting a research agenda to accelerate translation.
Freedman AN , Sansbury LB , Figg WD , Potosky AL , Weiss Smith SR , Khoury MJ , Nelson SA , Weinshilboum RM , Ratain MJ , McLeod HL , Epstein RS , Ginsburg GS , Schilsky RL , Liu G , Flockhart DA , Ulrich CM , Davis RL , Lesko LJ , Zineh I , Randhawa G , Ambrosone CB , Relling MV , Rothman N , Xie H , Spitz MR , Ballard-Barbash R , Doroshow JH , Minasian LM . J Natl Cancer Inst 2010 102 (22) 1698-705
|
| Genetic testing for CYP450 polymorphisms to predict response to clopidogrel: current evidence and test availability. Application: pharmacogenomics.
Ned RM . PLoS Curr 2010 2
|
| Genome-wide association studies in pharmacogenomics: untapped potential for translation.
Guessous I , Gwinn M , Khoury MJ . Genome Med 2009 1 (4) 46
|
| Health-related direct-to-consumer genetic tests: a public health assessment and analysis of practices related to Internet-based tests for risk of thrombosis.
Goddard K A B, Robitaille J, Dowling N F, Parrado A R, Fishman J, Bradley L A, Moore C A, Khoury M J. Public health genomics 2008 12(2) 92-104 . Public health genomics 2008 12(2) 92-104
|
| Intention to analyze in pharmacogenomics studies.
Gwinn Marta, Guessous Idris, Khoury Muin. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008 17(3) 740; author reply 740-1 . Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008 17(3) 740; author reply 740-1
|
| A public health approach to pharmacogenomics and gene-based diagnostic tests.
Davis Robert L, Khoury Muin J. Pharmacogenomics 2006 7(3) 331-7 . Pharmacogenomics 2006 7(3) 331-7
|
| The epidemiologic approach to pharmacogenomics.
Little Julian, Sharp Linda, Khoury Muin J, Bradley Linda, Gwinn Marta. American journal of pharmacogenomics : genomics-related research in drug development and clinical practice 2005 5(1) 1-20 . American journal of pharmacogenomics : genomics-related research in drug development and clinical practice 2005 5(1) 1-20
|
- Page last reviewed:Feb 1, 2024
- Content source: